|Progenics Pharmaceuticals, Inc.||(NQ: PGNX)|
4.180 USD -0.130 (-3.02%)
Streaming Delayed Price / Updated: 10:38 AM EDT, May 20, 2013 / Add to My Watchlist
Price and VolumeDetailed Quote
Featured NewsMore News
Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation,
March 19, 2013
Featured NewsRead More
Which Biotech Companies Are Turning the Tables on Patent Cliffs?
January 14, 2013
MedImmune Announces Agreement with Progenics Pharmaceuticals to Develop Therapies Against Serious Bacterial Infections
December 17, 2012
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
May 28, 2008
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here